GKB Ophthalmics Ltd.
Snapshot View

94.00 -4.00 ▼-4.1%

05 August 2021, 04:00:00 P.M.
Volume: 1,607

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.gkb.net
Financial Indicators
Market Cap 47.38 Cr.
Earnings per share (EPS) -1.80 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE - Trailing Twelve Months Ending 2021-03
Book Value / Share 124.30 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.76 Calculated using Price: 94.00
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.50 Cr. 5,040,580 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-4.08%
1 Week
+5.44%
1 Month
-12.44%
3 Month
+34.86%
6 Month
+51.98%
1 Year
+70.14%
2 Year
+104.35%
5 Year
+35.54%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 9.16 -3.10 6.60 -3.30 9.32 5.65 -2.12 -2.52 -4.41
Return on Capital Employed (%) 13.71 3.36 14.52 0.82 18.94 7.99 0.25 -0.34 -1.37
Return on Assets (%) 4.56 -1.52 3.39 -1.78 5.48 3.34 -1.15 -1.36 -2.41

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 35 35 40 40 45 47 45 55 59
Non Curr. Liab. 4 4 3 2 2 2 2 5 5
Curr. Liab. 31 34 30 33 23 37 36 37 41
Minority Int.
Equity & Liab. 71 73 73 75 69 86 83 97 106
Non Curr. Assets 27 27 29 29 18 19 19 33 33
Curr. Assets 44 45 43 46 51 66 64 64 73
Misc. Exp. not W/O
Total Assets 71 73 73 75 69 86 83 97 106

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 39 43 41 35 44 74 77 57 58
Other Income 1 1 1 1 2 1 0 2 1
Total Income 39 43 42 36 46 75 78 59 59
Total Expenditure -32 -40 -34 -34 -46 -72 -76 -56 -56
PBIDT 8 4 8 1 0 3 2 3 3
Interest -3 -3 -3 -3 -2 -1 -1 -1 -1
Depreciation -1 -1 -1 -2 -1 -1 -2 -4 -4
Taxation -1 0 -2 1 -4 0 0 0
Exceptional Items -1 0 1 11 3
PAT 3 -1 2 -1 4 3 -1 -1 -2

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 3 3 6 7 -11 -3 -3 4 3
Cash Fr. Inv. -5 -2 -2 -1 15 4 1 -10 -4
Cash Fr. Finan. 2 -1 -5 -6 -3 -1 1 13 3
Net Change 0 1 0 1 0 -1 0 7 2
Cash & Cash Eqvt 2 2 2 3 3 2 2 9 12

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 48.41 48.41 48.53 48.97 48.98 49.04 49.52 59.44 59.24
Public 51.59 51.59 51.47 51.03 51.02 50.96 50.48 40.56 40.76
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 05 Aug 2021
Board Meeting Intimation for Considering And Taking On Record The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2021.
GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2021.

The Notice can be accessed at the Companys website at www.gkb.net

Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 which has been closed will now re-open on Monday August 16 2021.

This communication has been sent to all the Directors and all the designated employees of the Company.
Tue, 20 Jul 2021
Shareholding for the Period Ended June 30 2021
GKB Ophthalmics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Mon, 12 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2021.

Kindly acknowledge receipt of the same.

Technical Scans View Details

Wed, 04 Aug 2021
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
S Close Above Last Week High
William %R Bearish William %R Bearish
Tue, 03 Aug 2021
Closing Above Previous High Closing Above Previous High
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%